An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

BACKGROUND: This study was designed to evaluate the occurrence and severity of ocular hyperemia in subjects with elevated intraocular pressure (IOP) due to primary open angle glaucoma (POAG) or ocular hypertension (OHT) following treatment with bimatoprost 0.01% in a real-world clinical setting. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Crichton, Andrew C, Discepola, Marino, Hutnik, Cindy ML, Yan, David B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529655/
https://www.ncbi.nlm.nih.gov/pubmed/23269858
http://dx.doi.org/10.2147/OPTH.S35394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529655/
https://www.ncbi.nlm.nih.gov/pubmed/23269858
http://dx.doi.org/10.2147/OPTH.S35394

Ejemplares similares